Condition: Obese · Sponsor: Göteborg University
The study investigates whether the addition of resolution molecules can inhibit inflammation and insulin resistance in human tissue taken from obese individuals, and whether the results of these studies correlate with patient-specific resolution phenotypes.
This description comes directly from the study's public registry record.
Emma Borgeson, PhD · +46313420000 · emma.borgeson@wlab.gu.se
Christina Biörserud, RN, PhD · +46313420000 · christina.biorserud@vgregion.se
Always discuss trial participation with your own doctor first.
| Sahlgrenska university hospital | Gothenburg, Västra Götaland County, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04255264